Sector & Market
Parmax Pharma Acquirers Seek Majority Control via SPA
Acquirers led by Dhiren C. Shah and Sunil C. Shah to acquire control of Parmax Pharma through share purchase agreement, preferential allotment, and open offer.
SPA executed at ₹35 per share for 43,210
